Found 1 clinical trials
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies
Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.
allogeneic transplantation
cancer
hematologic malignancy
investigational treatment
- 0 views
- 16 Feb, 2024
- 4 locations